SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-026192
Filing Date
2022-05-13
Accepted
2022-05-13 09:50:43
Documents
14
Period of Report
2022-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159911-8k_longeveron.htm   iXBRL 8-K 30338
2 PRESS RELEASE OF THE COMPANY, DATED MAY 13, 2022 ea159911ex99-1_longeveron.htm EX-99.1 70494
6 GRAPHIC ex99-1_001.jpg GRAPHIC 7297
  Complete submission text file 0001213900-22-026192.txt   298470

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lgvn-20220513.xsd EX-101.SCH 3039
4 XBRL LABEL FILE lgvn-20220513_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE lgvn-20220513_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159911-8k_longeveron_htm.xml XML 3713
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 22920697
SIC: 2834 Pharmaceutical Preparations